Growth Metrics

Sanara MedTech (SMTI) Return on Capital Employed (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Return on Capital Employed for 13 consecutive years, with 0.09% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed rose 15.0% year-over-year to 0.09%, compared with a TTM value of 0.09% through Sep 2025, up 15.0%, and an annual FY2024 reading of 0.1%, down 2.0% over the prior year.
  • Return on Capital Employed was 0.09% for Q3 2025 at Sanara MedTech, up from 0.02% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.09% in Q3 2025 and bottomed at 0.34% in Q2 2022.
  • Average Return on Capital Employed over 5 years is 0.14%, with a median of 0.12% recorded in 2021.
  • The sharpest move saw Return on Capital Employed soared 70bps in 2021, then dropped -22bps in 2022.
  • Year by year, Return on Capital Employed stood at 0.24% in 2021, then decreased by -9bps to 0.26% in 2022, then soared by 73bps to 0.07% in 2023, then increased by 22bps to 0.05% in 2024, then skyrocketed by 258bps to 0.09% in 2025.
  • Business Quant data shows Return on Capital Employed for SMTI at 0.09% in Q3 2025, 0.02% in Q2 2025, and 0.06% in Q1 2025.